Innate and Adaptive Interferons Suppress IL-1α and IL-1β Production by Distinct Pulmonary Myeloid Subsets during Mycobacterium tuberculosis Infection

Immunity

Volumn 35, Issue 6, 2011, Pages 1023-1034

  Mayer Barber, Katrin D ^a   Andrade, Bruno B ^a   Barber, Daniel L ^a   Hieny, Sara ^a   Feng, Carl G ^a   Caspar, Patricia ^a   Oland, Sandy ^a   Gordon, Siamon ^b   Sher, Alan ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; DATA ANALYSIS; HOST RESISTANCE; HUMAN; HUMAN CELL; IN VIVO STUDY; LUNG ALVEOLUS CELL; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SINGLE CELL ANALYSIS; TUBERCULOSIS;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, LY; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HUMANS; INTERFERONS; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; MYELOID CELLS; PHAGOCYTES; SIGNAL TRANSDUCTION; TUBERCULOSIS, PULMONARY;

EID: 84255162073     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2011.12.002     Document Type: Article

References (48)

1. Antonelli L.R., Gigliotti Rothfuchs A., Gonçalves R., Roffê E., Cheever A.W., Bafica A., Salazar A.M., Feng C.G., Sher A. Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J. Clin. Invest. 2010, 120:1674-1682.
2. Berry M.P., Graham C.M., McNab F.W., Xu Z., Bloch S.A., Oni T., Wilkinson K.A., Banchereau R., Skinner J., Wilkinson R.J., et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010, 466:973-977.
3. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm. Nat. Immunol. 2010, 11:889-896.
4. Chang E.Y., Guo B., Doyle S.E., Cheng G. Cutting edge: Involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J. Immunol. 2007, 178:6705-6709.
5. Cheong C., Matos I., Choi J.H., Dandamudi D.B., Shrestha E., Longhi M.P., Jeffrey K.L., Anthony R.M., Kluger C., Nchinda G., et al. Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell 2010, 143:416-429.
6. Cooper A.M., Mayer-Barber K.D., Sher A. Role of innate cytokines in mycobacterial infection. Mucosal Immunol. 2011, 4:252-260.
7. De Trez C., Magez S., Akira S., Ryffel B., Carlier Y., Muraille E. iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice. PLoS Pathog. 2009, 5:e1000494.
8. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009, 27:519-550.
9. Dinarello C.A. How interleukin-1β induces gouty arthritis. Arthritis Rheum. 2010, 62:3140-3144.
10. Dunay I.R., Damatta R.A., Fux B., Presti R., Greco S., Colonna M., Sibley L.D. Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity 2008, 29:306-317.
11. Flynn J.L., Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 2001, 19:93-129.
12. Fremond C.M., Togbe D., Doz E., Rose S., Vasseur V., Maillet I., Jacobs M., Ryffel B., Quesniaux V.F. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J. Immunol. 2007, 179:1178-1189.
13. Garlanda C., Di Liberto D., Vecchi A., La Manna M.P., Buracchi C., Caccamo N., Salerno A., Dieli F., Mantovani A. Damping excessive inflammation and tissue damage in Mycobacterium tuberculosis infection by Toll IL-1 receptor 8/single Ig IL-1-related receptor, a negative regulator of IL-1/TLR signaling. J. Immunol. 2007, 179:3119-3125.
14. Geissmann F., Gordon S., Hume D.A., Mowat A.M., Randolph G.J. Unravelling mononuclear phagocyte heterogeneity. Nat. Rev. Immunol. 2010, 10:453-460.
15. GeurtsvanKessel C.H., Lambrecht B.N. Division of labor between dendritic cell subsets of the lung. Mucosal Immunol. 2008, 1:442-450.
16. Guarda G., Dostert C., Staehli F., Cabalzar K., Castillo R., Tardivel A., Schneider P., Tschopp J. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 2009, 460:269-273.
17. Guarda G., Braun M., Staehli F., Tardivel A., Mattmann C., Förster I., Farlik M., Decker T., Du Pasquier R.A., Romero P., Tschopp J. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 2011, 34:213-223.
18. Guler R., Parihar S.P., Spohn G., Johansen P., Brombacher F., Bachmann M.F. Blocking IL-1α but not IL-1β increases susceptibility to chronic Mycobacterium tuberculosis infection in mice. Vaccine 2011, 29:1339-1346.
19. Guma M., Ronacher L., Liu-Bryan R., Takai S., Karin M., Corr M. Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation. Arthritis Rheum. 2009, 60:3642-3650.
20. Hu X., Ho H.H., Lou O., Hidaka C., Ivashkiv L.B. Homeostatic role of interferons conferred by inhibition of IL-1-mediated inflammation and tissue destruction. J. Immunol. 2005, 175:131-138.
21. Hu X., Paik P.K., Chen J., Yarilina A., Kockeritz L., Lu T.T., Woodgett J.R., Ivashkiv L.B. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 2006, 24:563-574.
22. Jayaraman P., Sada-Ovalle I., Beladi S., Anderson A.C., Dardalhon V., Hotta C., Kuchroo V.K., Behar S.M. Tim3 binding to galectin-9 stimulates antimicrobial immunity. J. Exp. Med. 2010, 207:2343-2354.
23. Joosten L.A., Netea M.G., Fantuzzi G., Koenders M.I., Helsen M.M., Sparrer H., Pham C.T., van der Meer J.W., Dinarello C.A., van den Berg W.B. Inflammatory arthritis in caspase 1 gene-deficient mice: Contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. Arthritis Rheum. 2009, 60:3651-3662.
24. Lin K.L., Suzuki Y., Nakano H., Ramsburg E., Gunn M.D. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J. Immunol. 2008, 180:2562-2572.
25. Lowes M.A., Chamian F., Abello M.V., Fuentes-Duculan J., Lin S.L., Nussbaum R., Novitskaya I., Carbonaro H., Cardinale I., Kikuchi T., et al. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc. Natl. Acad. Sci. USA 2005, 102:19057-19062.
26. Manca C., Tsenova L., Bergtold A., Freeman S., Tovey M., Musser J.M., Barry C.E., Freedman V.H., Kaplan G. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha /beta. Proc. Natl. Acad. Sci. USA 2001, 98:5752-5757.
27. Manca C., Tsenova L., Freeman S., Barczak A.K., Tovey M., Murray P.J., Barry C., Kaplan G. Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J. Interferon Cytokine Res. 2005, 25:694-701.
28. Masters S.L., Mielke L.A., Cornish A.L., Sutton C.E., O'Donnell J., Cengia L.H., Roberts A.W., Wicks I.P., Mills K.H., Croker B.A. Regulation of interleukin-1beta by interferon-gamma is species specific, limited by suppressor of cytokine signalling 1 and influences interleukin-17 production. EMBO Rep. 2010, 11:640-646.
29. Mayer-Barber K.D., Barber D.L., Shenderov K., White S.D., Wilson M.S., Cheever A., Kugler D., Hieny S., Caspar P., Núñez G., et al. Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 2010, 184:3326-3330.
30. McElvania Tekippe E., Allen I.C., Hulseberg P.D., Sullivan J.T., McCann J.R., Sandor M., Braunstein M., Ting J.P. Granuloma formation and host defense in chronic Mycobacterium tuberculosis infection requires PYCARD/ASC but not NLRP3 or caspase-1. PLoS ONE 2010, 5:e12320.
31. North R.J., Jung Y.J. Immunity to tuberculosis. Annu. Rev. Immunol. 2004, 22:599-623.
32. Novikov A., Cardone M., Thompson R., Shenderov K., Kirschman K.D., Mayer-Barber K.D., Myers T.G., Rabin R.L., Trinchieri G., Sher A., Feng C.G. Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1β production in human macrophages. J. Immunol. 2011, 187:2540-2547.
33. Rayamajhi M., Humann J., Kearney S., Hill K.K., Lenz L.L. Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections. Virulence 2010, 1:418-422.
34. Rayamajhi M., Humann J., Penheiter K., Andreasen K., Lenz L.L. Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma. J. Exp. Med. 2010, 207:327-337.
35. Redford P.S., Boonstra A., Read S., Pitt J., Graham C., Stavropoulos E., Bancroft G.J., O'Garra A. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. Eur. J. Immunol. 2010, 40:2200-2210.
36. Redford P.S., Murray P.J., O'Garra A. The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol. 2011, 4:261-270.
37. Saunders B.M., Briscoe H., Britton W.J. T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection. Clin. Exp. Immunol. 2004, 137:279-287.
38. Schindler R., Ghezzi P., Dinarello C.A. Interferons as inhibitors of interleukin 1 induced interleukin 1 synthesis. Lymphokine Res. 1989, 8:275-280.
39. Serbina N.V., Salazar-Mather T.P., Biron C.A., Kuziel W.A., Pamer E.G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003, 19:59-70.
40. Sköld M., Behar S.M. Tuberculosis triggers a tissue-dependent program of differentiation and acquisition of effector functions by circulating monocytes. J. Immunol. 2008, 181:6349-6360.
41. Stanley S.A., Johndrow J.E., Manzanillo P., Cox J.S. The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J. Immunol. 2007, 178:3143-3152.
42. Thacker S.G., Berthier C.C., Mattinzoli D., Rastaldi M.P., Kretzler M., Kaplan M.J. The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: Potential role in atherogenesis and renal vascular rarefaction. J. Immunol. 2010, 185:4457-4469.
43. Tilg H., Mier J.W., Vogel W., Aulitzky W.E., Wiedermann C.J., Vannier E., Huber C., Dinarello C.A. Induction of circulating IL-1 receptor antagonist by IFN treatment. J. Immunol. 1993, 150:4687-4692.
44. Trinchieri G. Type I interferon: Friend or foe?. J. Exp. Med. 2010, 207:2053-2063.
45. Turner J., Gonzalez-Juarrero M., Ellis D.L., Basaraba R.J., Kipnis A., Orme I.M., Cooper A.M. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J. Immunol. 2002, 169:6343-6351.
46. Varol C., Yona S., Jung S. Origins and tissue-context-dependent fates of blood monocytes. Immunol. Cell Biol. 2009, 87:30-38.
47. Walter K., Hölscher C., Tschopp J., Ehlers S. NALP3 is not necessary for early protection against experimental tuberculosis. Immunobiology 2010, 215:804-811.
48. Wolf A.J., Linas B., Trevejo-Nuñez G.J., Kincaid E., Tamura T., Takatsu K., Ernst J.D. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 2007, 179:2509-2519.